# Use of Medical Marijuana or Hemp Doesn’t Excuse Drug Testing Violations > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/2026-cannabis-federal-workplace-regulations/ > **Published:** 2026-03-05T12:58:12-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:11:30-04:00 > **Clinical Summary:** Understand 2026 cannabis federal workplace regulations clarifying medical marijuana does not exempt workers from drug testing violations or employment risks. --- ✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicyHempTHCSafetyIndustry Why This Matters Clinicians should be aware that the Department of Transportation’s policy means patients using [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) or hemp products may still fail workplace drug tests and face employment consequences, regardless of medical legitimacy or state-level legalization. This creates a clinical counseling obligation to inform patients that [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) use carries occupational risks that extend beyond their direct medical care. Clinicians should document medical justification for cannabis recommendations and discuss these federal employment implications with working-age patients to support informed decision-making. Clinical Summary The Department of Transportation has clarified that medical marijuana and hemp oil use do not provide exemptions from workplace [drug testing](https://cedclinic.com/how-long-does-weed-stay-in-your-system/) policies, even when THC is detected in screening results. This federal guidance, issued through the DOT’s Substance Abuse Professional program, reinforces that transportation workers subject to DOT regulations cannot claim medical [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) as a valid defense against positive drug tests or related employment consequences. The ruling applies regardless of state-level legalization of medical cannabis, establishing a significant disconnect between state medical cannabis programs and federal workplace safety requirements. For clinicians prescribing cannabis to patients in safety-sensitive occupations such as commercial drivers, pilots, or transportation workers, this decision creates an important clinical and ethical consideration regarding informed consent and employment risk. Physicians should explicitly counsel patients in regulated industries about the federal employment consequences of medical cannabis use, as continued DOT testing policies may result in job loss or license suspension despite legitimate medical authorization at the state level. When considering cannabis as a treatment option, clinicians must discuss these occupational barriers with patients and document their informed consent regarding federal workplace consequences. Dr. Caplan’s Take “What we’re seeing with the DOT’s position is a collision between federal prohibition and legitimate medical practice, and the burden falls entirely on my patients who are using cannabis under state law for genuine therapeutic reasons. We need employers and regulators to understand that a positive drug test doesn’t tell you whether someone is impaired at work, and blanket policies that ignore medical authorization are creating a situation where patients have to choose between their treatment and their employment. Until federal policy catches up with the clinical evidence and state laws, we physicians have an obligation to document medical necessity carefully and help our patients navigate these regulatory gray zones.” Clinical Perspective This Department of Transportation guidance clarifying that medical marijuana and hemp use do not exempt workers from drug testing violations has important implications for clinicians who care for safety-sensitive employees. While the legal status of cannabis continues to evolve across states, federal transportation safety standards remain stringent, reflecting legitimate concerns about impaired driving and workplace safety. Clinicians should be aware that prescribing or recommending cannabis products to patients in transportation, aviation, nuclear, or other federally regulated safety-sensitive positions may inadvertently jeopardize their employment, regardless of medical indication or state-level legalization. When considering cannabis as a therapeutic option, healthcare providers should counsel patients about these occupational risks and discuss them transparently before initiation, ensuring informed decision-making about potential workplace consequences. A practical approach involves documenting the clinical rationale for cannabis recommendations while explicitly discussing federal workplace policies with affected patients and encouraging them to verify their employer’s and industry’s specific policies before 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Use+Of+Medical+Marijuana+Or+Hemp+Doesn%27t+Excuse+Drug+Testing+Violations%2C+Trump%27s+...+%40drcaplan&url=https%3A%2F%2Fwww.marijuanamoment.net%2Fuse-of-medical-marijuana-or-hemp-doesnt-excuse-drug-testing-violations-trumps-transportation-department-warns%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.marijuanamoment.net%2Fuse-of-medical-marijuana-or-hemp-doesnt-excuse-drug-testing-violations-trumps-transportation-department-warns%2F) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Use+Of+Medical+Marijuana+Or+Hemp+Doesn%27t+Excuse+Drug+Testing+Violations%2C+Trump%27s+...+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.marijuanamoment.net%2Fuse-of-medical-marijuana-or-hemp-doesnt-excuse-drug-testing-violations-trumps-transportation-department-warns%2F) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.marijuanamoment.net/use-of-medical-marijuana-or-hemp-doesnt-excuse-drug-testing-violations-trumps-transportation-department-warns/](https://www.marijuanamoment.net/use-of-medical-marijuana-or-hemp-doesnt-excuse-drug-testing-violations-trumps-transportation-department-warns/) Further Reading Evidence Watch[Regulatory Digest 2026-03-08](https://cedclinic.com/regulatory-digest-2026-03-09/)Cannabis Memes[College is hard lmao](https://cedclinic.com/college-is-hard-lmao/)CED Clinic Blog[Cannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years](https://cedclinic.com/cannabis-beverage-substitution-alcohol-new-york-five-years/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [With Marijuana Rescheduling Still Pending, Federal Workplace Drug Testing Rules Aren't …](https://cedclinic.com/federal-workplace-drug-testing-policies-marijuana-update/) Explore how pending marijuana rescheduling affects federal workplace drug testing rules and employee protections. [Read More](https://cedclinic.com/federal-workplace-drug-testing-policies-marijuana-update/) [Marijuana reclassification may impact drug testing for private pilots | FOX 13 Tampa Bay](https://cedclinic.com/marijuana-reclassification-impact-drug-testing-pilots/) Learn about the potential impact of marijuana reclassification on drug testing policies for private pilots. [Learn More](https://cedclinic.com/marijuana-reclassification-impact-drug-testing-pilots/) [White House Drug Czar Clarifies That Marijuana Is ‘Still Illegal’ Following Trump …](https://cedclinic.com/white-house-drug-czar-clarifies-that-marijuana-is-still-illegal-following-trump/) Understand federal perspectives on marijuana legality and its implications for drug testing and employment. [Discover More](https://cedclinic.com/white-house-drug-czar-clarifies-that-marijuana-is-still-illegal-following-trump/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).